Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eduard Monsó has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prospective Validation of Computer-Assisted Detection of Pulmonary Nodules and Lung Cancer in Chest X-Rays

    by Marta Andreu, Carles Grimau, Mariona Quintana, Marta Cufí, Carme Lozano, Eva Castañer, Xavier Gallardo, Pau Esteve, Judith Juan, Inés Ruiz-Gemar, et al.

    Background: Computer-aided diagnosis (CAD) algorithms may be useful for the detection of pulmonary nodules, some of them early-stage primary lung cancers (LCs). Method: A CAD algorithm for the identification of pulmonary nodules in chest X-rays was used in a prospective cohort of patients without respiratory symptoms who underwent an X-ray. Chest X-rays were sorted according to the probability of the presence of a pulmonary nodule, and images placed in the higher percentiles by the algorithm were read by a radiologist, checked for previous diagnoses, and assessed for new primary LCs. Results: The radiological study confirmed the presence of a pulmonary nodules in 88 out of the 1842 chest X-rays placed ≥70th percentile (4.8%, 95% confidence interval 3.8–5.7%), 44 of which were found to be malignant (50%), and seven of them undiagnosed primary LCs (7.9%). The CAD algorithm prompted a new diagnosis of primary LC in 0.4% (95% confidence interval 0.1–0.7%), of the high-probability chest X-rays. Conclusions: A CAD algorithm prospectively identified pulmonary nodules among patients without respiratory symptoms. Radiologist-confirmed round opacities were found in 4.8% of the high-probability images, and previously undiagnosed primary lung cancers accounted for near 8% of confirmed pulmonary nodules.

  • Open Access

    Prospective Validation of Computer-Assisted Detection of Early Lung Cancer in Chest X-Rays

    by Marta Andreu, Carles Grimau, Mariona Quintana, Marta Cufi, Carme Lozano, Eva Castañer, Xavier Gallardo, Pau Esteve, Judith Juan, Ines Ruiz-Gemar, et al.

    Background: Computer-aided diagnosis (CAD) algorithms may be useful for the detection of pulmonary nodules, some of them early-stage primary lung cancers (LCs). Method: A CAD algorithm for the identification of pulmonary nodules in chest x-rays was used in a prospective cohort of patients without respiratory symptoms who underwent an x-ray. Chest x-rays were sorted according to the probability of the presence of a pulmonary nodule, and images placed in the highest percentiles by the algorithm were read by a radiologist, checked for previous diagnoses, and assessed for new primary LCs. Results: The radiological study confirmed the presence of a round opacities in 88 out of the 1842 chest x-rays placed in the highest percentiles (4.8%), 44 of which were found to be malignant (50%), and 7 of them undiagnosed primary LCs (7.9%). The CAD algorithm prompted a new diagnosis of primary LC in 0.4% of the sorted chest x-rays. Conclusion: A CAD algorithm prospectively identified chest x-rays with a high probability of pulmonary nodules among patients without respiratory symptoms. Radiologist-confirmed nodules were found in 4.8% of high-probability images, and previously undiagnosed primary lung cancers accounted for near 8% of confirmed round opacities and 1% of high-probability chest x-rays.

  • Open Access

    Bronchial and Systemic Relationships of Haemophilus in Chronic Obstructive Pulmonary Disease

    by Eduard Monsó, Carme Casadevall, Sara Quero, Sergi Pascual-Guàrdia, César Jésse Enríquez-Rodríguez, Laura Millares, Concepción Montón, Rosa Faner, Silvia Capilla, Luis Miguel Seijo, et al.

    The aim of the study was to assess the microbial composition of bronchial secretions in chronic obstructive pulmonary disease (COPD), focusing on the impact of the exacerbation patterns on the common components of the respiratory flora and their relationship with inflammatory proteins. A total of 72 clinically stable COPD patients provided sputum and blood samples for 16S rRNA gene amplification and peripheral biomarkers. Beta-diversity analyses of the bronchial microbiome showed significant differences between infrequent and frequent (≥2) exacerbators (p = 0.001). Haemophilus was underrepresented in frequent exacerbators (relative abundance [RA] 0.07 [0.003–0.31] vs. 0.24 [0.06–2.36], p = 0.02) while the presence of Pseudomonas was increased (7.70 [0.66–11.68] vs. 1.11 [0.37–2.88], p = 0.01). Eight common taxa, Prevotella, Moryella, Atopobium, Megasphaera, Parvimonas, Veillonella, Bulleidia and Selenomonas, showed significant decreases in their RAs when exacerbations required hospitalization. RAs of Haemophilus and eight common taxa were positively correlated (p < 0.01). Among them, Porphyromonas, Leptotrichia and Selenomonas showed a negative correlation with blood interleukin-8 (IL-8) (p < 0.01) and an equivalent correlation was found for Haemophilus parainfluenzae. Frequent exacerbations cause a decrease in the RA of Haemophilus and have a more extensive impact when hospitalization is required. The RAs of common bronchial bacteria were closely related and some of them were inversely associated with blood IL-8 levels.

  • Open Access

    Sex-Specific Plasma Metabolomic Signatures in COPD Reveal Creatine, Purine/Urate, and Bile-Acid Axes

    by Carme Casadevall, César Jessé Enríquez-Rodríguez, Alexandra Eliassaf, Ady Castro-Acosta, Rosa Faner, José Luis López-Campos, Eduard Monsó, Sergi Pascual-Guàrdia, Ramon Camps-Ubach, Borja G. Cosío, et al.

    Metabolomic studies in COPD reveal systemic metabolic perturbations, yet sex is often treated as a covariate rather than a biological driver. We aimed to identify plasma metabolites differentiating COPD from controls and to define sex-specific metabolic signatures in both groups. Methods: In this controlled observational study (BIOMEPOC cohort), untargeted plasma metabolomics was performed by LC-MS/MS. Differential abundance was tested across four contrasts (COPD vs. controls; men vs. women within controls; men vs. women within COPD; sex-by-disease interaction) with a false discovery rate (FDR) correction. Because smoking history differed between COPD and controls, a post hoc ever-smokers analysis was conducted. Results: COPD differed from controls in nine metabolites (all decreased): DL-stachydrine, 3-methyl-L-histidine, fructose, pipecolinic and nipecotic acids, 5-nitro-o-toluidine, conjugated linoleic acid, aminoadipate, and creatinine. This pattern is compatible with metabolic depletion, remodeling, and/or altered flux across multiple compartments rather than simple substrate deficiency, spanning muscle-related pools, amino acid handling, carbohydrate-associated metabolism, and exposome-linked inputs. In ever-smokers, results were directionally consistent, with five metabolites remaining nominally significant. Among controls, five metabolites were higher in men after FDR correction (PABA, cis-4-hydroxy-D-proline, N-acetylasparagine, deoxycarnitine, and creatinine), consistent with physiological sex dimorphism in energy pathways, connective-tissue remodeling, and diet/microbiome-related metabolism. Within COPD, six metabolites differed by sex after FDR correction, defining three axes: creatine energy buffering (men: higher GAA/creatinine, lower creatine), purine/urate handling (men: higher urate), and conjugated bile acids (men: higher GCDCA), implicating muscle bioenergetics, redox/inflammatory tone, and gut–liver crosstalk. Conclusions: Plasma metabolomics identifies a pattern compatible with systemic remodeling in COPD and sex-associated divergences in creatine, purine/urate, and bile-acid pathways, supporting a sex-influenced view of systemic COPD heterogeneity and highlighting targets for mechanistic validation.


  • Open Access

    Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373

    by César Jessé Enríquez-Rodríguez, Bella Agranovich, Sergi Pascual-Guàrdia, Rosa Faner, Ramon Camps-Ubach, Ady Castro-Acosta, José Luis López-Campos, Germán Peces-Barba, Luis Seijo, Oswaldo Antonio Caguana-Vélez, et al.

    In the original publication, the authors identified a mistake in Table 4 as published

  • Open Access

    Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients

    by César Jessé Enríquez-Rodríguez, Bella Agranovich, Sergi Pascual-Guàrdia, Rosa Faner, Ramon Camps-Ubach, Ady Castro-Acosta, José Luis López-Campos, Germán Peces-Barba, Luis Seijo, Oswaldo Antonio Caguana-Vélez, et al.

    Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with high mortality. Early identification of patients at increased risk of death remains a major clinical challenge. This pilot study aimed to explore whether plasma metabolomic profiling could aid in the prediction of long-term (7-year) mortality and provide insight into potential underlying mechanisms. Plasma samples from 54 randomly selected stable COPD patients were analyzed using both untargeted and semi-targeted LC-MS approaches. After excluding patients with unclear death data, non-COPD-related deaths and metabolomic outliers, 41 individuals were included in the final analysis. During follow-up, 13 patients (32%) died, and 28 survived. Univariate analysis identified 12 metabolites—mainly amino acids—that differed significantly between the two groups. Functional analysis suggested a significant disruption in energy production pathways. Predictive models developed using machine learning algorithms, consisting of either ten metabolites alone or nine metabolites plus FEV1, achieved high accuracy for 7-year mortality prediction, with the latter model performing slightly better. Internal validation was conducted using five-fold cross-validation. While exploratory, these findings support the hypothesis that early metabolic alterations, particularly in energy pathways, may contribute to long-term mortality risk in stable COPD patients, and could complement traditional prognostic markers such as FEV1.


  • Open Access

    Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients

    by Carme Casadevall, Bella Agranovich, Cesar Jesse Enríquez-Rodríguez, Rosa Faner, Sergi Pascual-Guàrdia, Ady Castro-Acosta, Ramon Camps-Ubach, Judith Garcia-Aymerich, Esther Barreiro, Eduard Monsó, et al.

    The analysis of blood metabolites may help identify individuals at risk of having COPD and offer insights into its underlying pathophysiology. This study aimed to identify COPD-related metabolic alterations and generate a biological signature potentially useful for screening purposes. Plasma metabolomic profiles from 91 COPD patients and 91 controls were obtained using complementary semi-targeted and untargeted LC-MS approaches. Univariate analysis identified metabolites with significant differences between groups, and enrichment analysis highlighted the most affected metabolic pathways. Multivariate analysis, including ROC curve assessment and machine learning algorithms, was applied to assess the discriminatory capacity of selected metabolites. After adjustment for major potential confounders, 56 metabolites showed significant differences between COPD patients and controls. The enrichment analysis revealed that COPD-associated metabolic alterations primarily involved lipid metabolism (especially fatty acids and acylcarnitines), followed by amino acid pathways and xenobiotics. A panel of 10 metabolites, mostly related to lipid metabolism, demonstrated high discriminatory performance for COPD (ROC-AUC: 0.916; 90.1% sensitivity and 89% specificity). These findings may contribute to improving screening strategies and a better understanding of COPD-related metabolic changes. However, our findings remain exploratory and should be interpreted with caution, needing further validation and mechanistic studies.


  • Open Access

    A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    by Cesar Jessé Enríquez-Rodríguez, Carme Casadevall, Rosa Faner, Sergi Pascual-Guardia, Ady Castro-Acosta, José Luis López-Campos, Germán Peces-Barba, Luis Seijo, Oswaldo Antonio Caguana-Vélez, Eduard Monsó, et al.

    Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality. Despite clinical predictors (age, severity, comorbidities, etc.) being established, proteomics offers comprehensive biological profiling to obtain deeper insights into COPD pathophysiology and survival prognoses. This pilot study aimed to identify proteomic footprints that could be potentially useful in predicting mortality in stable COPD patients. Plasma samples from 40 patients were subjected to both blind (liquid chromatography–mass spectrometry) and hypothesis-driven (multiplex immunoassays) proteomic analyses supported by artificial intelligence (AI) before a 4-year clinical follow-up. Among the 34 patients whose survival status was confirmed (mean age 69 ± 9 years, 29.5% women, FEV1 42 ± 15.3% ref.), 32% were dead in the fourth year. The analysis identified 363 proteins/peptides, with 31 showing significant differences between the survivors and non-survivors. These proteins predominantly belonged to different aspects of the immune response (12 proteins), hemostasis (9), and proinflammatory cytokines (5). The predictive modeling achieved excellent accuracy for mortality (90%) but a weaker performance for days of survival (Q2 0.18), improving mildly with AI-mediated blind selection of proteins (accuracy of 95%, Q2 of 0.52). Further stratification by protein groups highlighted the predictive value for mortality of either hemostasis or pro-inflammatory markers alone (accuracies of 95 and 89%, respectively). Therefore, stable COPD patients’ proteomic footprints can effectively forecast 4-year mortality, emphasizing the role of inflammatory, immune, and cardiovascular events. Future applications may enhance the prognostic precision and guide preventive interventions.


  • Microbiome in chronic obstructive pulmonary disease

    by Eduard Monsó

    The introduction of culture-independent techniques for the microbiological analysis of respiratory samples has confirmed that the respiratory system hosts a large number of microorganisms, which include a wide range of bacteria. The regular exposure to tobacco smoke changes the microbiome in healthy smokers, first in the oropharynx, increasing the presence of a restricted number of genera which attain high relative abundance, a pattern that may be considered as dysbiosis. In chronic obstructive pulmonary disease (COPD), microbiome analyses of sputum samples have demonstrated an important decline in bacterial diversity, with a change to a restricted flora with an overrepresentation of the Proteobacteria phylum, which include most of the bacteria commonly considered as potentially pathogenic microorganisms, paralleled by a decline in the relative abundance of microorganisms part of the Firmicutes phylum. In exacerbations, specific bacteria overrepresented in microbiome analyses and potentially causal of the acute episode may not be recovered by sputum culture, while colonizing microorganisms grow easily, in spite that their relative abundance have not changed from previous stability. This situation has been described in patients showing chronic colonization by Pseudomonas aeruginosa, who suffer from exacerbations that in most cases are due to other PPMs, in spite of the persistence of positive cultures for the colonizing Pseudomonas strains. Interaction between different microorganisms can be addressed through microbiome analyses, and functional metagenomics, that describes the genomic potential of the community, has shown that, in spite that the bronchial microbiome as a whole may not change significantly, clear changes in carbohydrate metabolism, cancer, cell growth and death, transport and catabolism pathways often appear during exacerbations. These functional changes may be important because through them the resident community as a whole show its power to modify important metabolic patterns.